Correction: BMC Complement Med Ther 21, 259 (2021)
https://doi.org/10.1186/s12906-021-03426-8
Following publication of the original article [1], the authors identified errors in Figs. 3(A), 7(e & k) in the article and Fig. S6 in the Additional file 1. The correct Figs. 3(A), 7(e & k), and Fig. S6(c-d) are shown in the revised version as following:
Fig. 3
Fig. 7
Fig. S6
Reference
Huang HJ, Chen JL, Liao JF, Chen YH, Chieu MW, Ke YY, et al. Lactobacillus plantarum PS128 prevents cognitive dysfunction in Alzheimer's disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis. BMC Complement Med Ther. 2021;21(1):259. https://doi.org/10.1186/s12906-021-03426-8.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Huang, HJ., Chen, JL., Liao, JF. et al. Correction: Lactobacillus plantarum PS128 prevents cognitive dysfunction in alzheimer’s disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis. BMC Complement Med Ther 22, 136 (2022). https://doi.org/10.1186/s12906-022-03596-z
Published:
DOI: https://doi.org/10.1186/s12906-022-03596-z